[go: up one dir, main page]

AU2001261516A1 - Semi-solid delivery vehicle and pharmaceutical compositions - Google Patents

Semi-solid delivery vehicle and pharmaceutical compositions

Info

Publication number
AU2001261516A1
AU2001261516A1 AU2001261516A AU6151601A AU2001261516A1 AU 2001261516 A1 AU2001261516 A1 AU 2001261516A1 AU 2001261516 A AU2001261516 A AU 2001261516A AU 6151601 A AU6151601 A AU 6151601A AU 2001261516 A1 AU2001261516 A1 AU 2001261516A1
Authority
AU
Australia
Prior art keywords
semi
delivery vehicle
pharmaceutical compositions
solid delivery
solid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001261516A
Inventor
Jorge Heller
Steven Y. Ng
Hui-Rong Shen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Heron Therapeutics LLC
Original Assignee
Advanced Polymer Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Polymer Systems Inc filed Critical Advanced Polymer Systems Inc
Publication of AU2001261516A1 publication Critical patent/AU2001261516A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A semi-solid delivery vehicle contains a polyorthoester and an excipient, and a semi-solid pharmaceutical composition contains an active agent and the delivery vehicle. The pharmaceutical composition may be a topical, syringable, or injectable formulation; and is suitable for local delivery of the active agent. Methods of treatment are also disclosed.
AU2001261516A 2000-05-11 2001-05-11 Semi-solid delivery vehicle and pharmaceutical compositions Abandoned AU2001261516A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56971700A 2000-05-11 2000-05-11
US09569717 2000-05-11
PCT/US2001/015409 WO2001085139A2 (en) 2000-05-11 2001-05-11 Semi-solid delivery vehicle and pharmaceutical compositions

Publications (1)

Publication Number Publication Date
AU2001261516A1 true AU2001261516A1 (en) 2001-11-20

Family

ID=24276565

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001261516A Abandoned AU2001261516A1 (en) 2000-05-11 2001-05-11 Semi-solid delivery vehicle and pharmaceutical compositions

Country Status (8)

Country Link
EP (1) EP1280558B1 (en)
AT (1) ATE311904T1 (en)
AU (1) AU2001261516A1 (en)
CA (1) CA2445638C (en)
DE (1) DE60115631T2 (en)
DK (1) DK1280558T3 (en)
ES (1) ES2253381T3 (en)
WO (1) WO2001085139A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050042194A1 (en) * 2000-05-11 2005-02-24 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
EP1315777B1 (en) 2000-09-06 2007-10-31 AP Pharma, Inc. Degradable polyacetal polymers
EP1395626A1 (en) * 2001-05-11 2004-03-10 AP Pharma, Inc. Peg-poe, peg-poe-peg, and poe-peg-poe block copolymers
US20020176844A1 (en) * 2001-05-11 2002-11-28 Ng Steven Y. Bioerodible polyorthoesters containing hydrogen bonding groups
US6524606B1 (en) 2001-11-16 2003-02-25 Ap Pharma, Inc. Bioerodible polyorthoesters containing amine groups
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
US7045589B2 (en) 2002-11-15 2006-05-16 A.P. Pharma, Inc. Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them
WO2006036936A2 (en) 2004-09-27 2006-04-06 Bridge Pharma, Inc. The s-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents
WO2008005371A2 (en) 2006-06-29 2008-01-10 Medtronic, Inc. Poly(orthoester) polymers, and methods of making and using same
CA2655809C (en) 2006-07-21 2013-10-01 Bridge Pharma, Inc. Dermal anesthetic compounds
US8475823B2 (en) 2008-04-18 2013-07-02 Medtronic, Inc. Baclofen formulation in a polyorthoester carrier
US8956642B2 (en) 2008-04-18 2015-02-17 Medtronic, Inc. Bupivacaine formulation in a polyorthoester carrier
KR102370470B1 (en) * 2013-03-15 2022-03-04 헤론 테라퓨틱스 인코포레이티드 Compositions of a polyorthoester and an aprotic solvent
HRP20202010T1 (en) * 2014-04-21 2021-03-05 Heron Therapeutics, Inc. POLYORTHOESTER PREPARATIONS AND ORGANIC ACID AS EXCIPIENT
JP2023515918A (en) 2020-01-13 2023-04-17 デュレクト コーポレーション Sustained release drug delivery system with reduced impurities and related methods
CN119463135A (en) * 2020-07-10 2025-02-18 南京海鲸药业股份有限公司 A series of polymers with acid-sensitive degradation and temperature-sensitive properties and drug-carrying compositions thereof
JP2024503402A (en) 2021-01-12 2024-01-25 デュレクト コーポレーション Sustained release drug delivery systems and related methods
WO2022152835A1 (en) * 2021-01-18 2022-07-21 Evonik Operations Gmbh High molecular weight triethylene-glycol polyorthoester iv (teg-poe iv) polymers and compositions for drug delivery and medical implants applications
EP4538310A1 (en) * 2022-01-20 2025-04-16 Nanjing Fantai Chemical Pharmaceutical Research Institute Series of polymers having properties of acid-sensitive degradation and temperature sensitivity and drug loading composition thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992011843A1 (en) * 1991-01-09 1992-07-23 Alza Corporation Bioerodible devices and compositions for diffusional release of agents
MY113268A (en) * 1992-12-29 2002-01-31 Insite Vision Incorporated Plasticized bioerodible controlled delivery system
US5968543A (en) * 1996-01-05 1999-10-19 Advanced Polymer Systems, Inc. Polymers with controlled physical state and bioerodibility
US5939453A (en) * 1998-06-04 1999-08-17 Advanced Polymer Systems, Inc. PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers

Also Published As

Publication number Publication date
CA2445638C (en) 2010-02-09
DK1280558T3 (en) 2005-12-27
DE60115631T2 (en) 2006-08-10
ES2253381T3 (en) 2006-06-01
DE60115631D1 (en) 2006-01-12
WO2001085139A3 (en) 2002-04-18
ATE311904T1 (en) 2005-12-15
EP1280558B1 (en) 2005-12-07
EP1280558A2 (en) 2003-02-05
CA2445638A1 (en) 2001-11-15
WO2001085139A2 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
TW200616650A (en) Semi-solid delivery vehicle and pharmaceutical compositions
AU2001261516A1 (en) Semi-solid delivery vehicle and pharmaceutical compositions
AU2274201A (en) Compounds and compositions for delivering active agents
WO2007133751A3 (en) Base-stabilized polyorthoester formulations
CA2370565A1 (en) Dermally applicable vitamin d-containing pharmaceutical compositions
WO2000007979A3 (en) Compounds and compositions for delivering active agents
HU230005B1 (en) Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
AU3435497A (en) Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies
ATE391708T1 (en) COMPOUNDS AND MIXTURES FOR ADMINISTRATION OF AN ACTIVE AGENT
WO1999015210A3 (en) Bioadhesive compositions and methods for topical administration of active agents
MXPA01008611A (en) Compounds and compositions for delivering active agents.
CA2366702A1 (en) Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
WO2001090091A8 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
EP1093819A3 (en) Compounds and compositions for delivering active agents
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
AU2001288460A1 (en) Compositions for treating sexual dysfunction, containing an no-donor and an antioxidant
WO2002045752A3 (en) Dermal anti-inflammatory composition
AU3492100A (en) Oxadiazole compounds and compositions for delivering active agents
WO2005007072A3 (en) Methods and pharmaceutical compositions for healing wounds
AU2084801A (en) Antiviral medication
WO2002015959A3 (en) Compounds and compositions for delivering active agents
WO2003066597A3 (en) Guanidino compounds
AU2001267561A1 (en) Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined withspecific pharmaceutical active agents
CA2348474A1 (en) Pharmaceutically active composition and dispensing device
WO2002006299A3 (en) Therapeutic uses for aminosterol compounds